{"id":"hdac","name":"Histone deacetylases (HDAC)","symbol":"HDAC1, HDAC2, HDAC3, HDAC6","route":"/targets/hdac/","asOf":"2026-09-10","xrefs":[{"hgnc":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:4852","ensembl":"https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000116478","uniprot":"https://www.uniprot.org/uniprotkb/Q13547/entry","alphafold-db":"https://alphafold.ebi.ac.uk/entry/Q13547","chembl":"https://www.ebi.ac.uk/chembl/explore/target/CHEMBL325","open-targets":"https://platform.opentargets.org/target/ENSG00000116478","civic":"https://civicdb.org/genes/3065/summary","oncokb":"https://www.oncokb.org/gene/HDAC1","cosmic":"https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=HDAC1","cbioportal":"https://www.cbioportal.org/results/mutations?cancer_study_list=msk_impact_2017&gene_list=HDAC1","depmap":"https://depmap.org/portal/gene/HDAC1?tab=overview","human-protein-atlas":"https://www.proteinatlas.org/ENSG00000116478-HDAC1","ncbi-gene":"https://www.ncbi.nlm.nih.gov/gene/3065","omim":"https://www.omim.org/entry/601241"},{"hgnc":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:4853","ensembl":"https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000196591","uniprot":"https://www.uniprot.org/uniprotkb/Q92769/entry","alphafold-db":"https://alphafold.ebi.ac.uk/entry/Q92769","chembl":"https://www.ebi.ac.uk/chembl/explore/target/CHEMBL1937","open-targets":"https://platform.opentargets.org/target/ENSG00000196591","civic":"https://civicdb.org/genes/3066/summary","oncokb":"https://www.oncokb.org/gene/HDAC2","cosmic":"https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=HDAC2","cbioportal":"https://www.cbioportal.org/results/mutations?cancer_study_list=msk_impact_2017&gene_list=HDAC2","depmap":"https://depmap.org/portal/gene/HDAC2?tab=overview","human-protein-atlas":"https://www.proteinatlas.org/ENSG00000196591-HDAC2","ncbi-gene":"https://www.ncbi.nlm.nih.gov/gene/3066","omim":"https://www.omim.org/entry/605164"},{"hgnc":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:4854","ensembl":"https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000171720","uniprot":"https://www.uniprot.org/uniprotkb/O15379/entry","alphafold-db":"https://alphafold.ebi.ac.uk/entry/O15379","chembl":"https://www.ebi.ac.uk/chembl/explore/target/CHEMBL1829","open-targets":"https://platform.opentargets.org/target/ENSG00000171720","civic":"https://civicdb.org/genes/8841/summary","oncokb":"https://www.oncokb.org/gene/HDAC3","cosmic":"https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=HDAC3","cbioportal":"https://www.cbioportal.org/results/mutations?cancer_study_list=msk_impact_2017&gene_list=HDAC3","depmap":"https://depmap.org/portal/gene/HDAC3?tab=overview","human-protein-atlas":"https://www.proteinatlas.org/ENSG00000171720-HDAC3","ncbi-gene":"https://www.ncbi.nlm.nih.gov/gene/8841","omim":"https://www.omim.org/entry/605166"},{"hgnc":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:14064","ensembl":"https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000094631","uniprot":"https://www.uniprot.org/uniprotkb/Q9UBN7/entry","alphafold-db":"https://alphafold.ebi.ac.uk/entry/Q9UBN7","chembl":"https://www.ebi.ac.uk/chembl/explore/target/CHEMBL1865","open-targets":"https://platform.opentargets.org/target/ENSG00000094631","civic":"https://civicdb.org/genes/10013/summary","oncokb":"https://www.oncokb.org/gene/HDAC6","cosmic":"https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=HDAC6","cbioportal":"https://www.cbioportal.org/results/mutations?cancer_study_list=msk_impact_2017&gene_list=HDAC6","depmap":"https://depmap.org/portal/gene/HDAC6?tab=overview","human-protein-atlas":"https://www.proteinatlas.org/ENSG00000094631-HDAC6","ncbi-gene":"https://www.ncbi.nlm.nih.gov/gene/10013","omim":"https://www.omim.org/entry/300272"}],"products":[{"id":"abt-301","name":"ABT-301","status":"phase-2","modality":"small molecule","route":"/drugs/abt-301/"},{"id":"resminostat","name":"Resminostat","modality":"Small-molecule HDAC inhibitor","route":"/drugs/resminostat/"},{"id":"vorinostat","name":"Vorinostat","status":"approved","modality":"Small-molecule pan-HDAC inhibitor (hydroxamate)","route":"/drugs/vorinostat/"}],"trials":[{"id":"mavoric","name":"MAVORIC","nct":"NCT01728805","phase":"3","status":"positive"},{"id":"nct00943449","name":"4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma","nct":"NCT00943449","phase":"2","status":"completed"},{"id":"nct01037478","name":"Resminostat (4SC-201) in Relapsed or Refractory Hodgkin's Lymphoma","nct":"NCT01037478","phase":"2","status":"completed"},{"id":"nct02953301","name":"Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)","nct":"NCT02953301","phase":"2","status":"completed"},{"id":"nct07244705","name":"A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC","nct":"NCT07244705","phase":"1/2","status":"recruiting"}],"pathways":[],"companies":["4sc","merck"],"keyPapers":[],"hotspots":[],"openQuestions":[],"assays":[],"resistance":[],"licence":"CC BY-NC 4.0, attribution to OnCo (https://onco.cc); commercial use needs a licence"}